Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 2876 - Provider product page

- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#2876, RRID:AB_2064177
- Product name
- Bcl-2 Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Storage
- -20°C
Submitted references Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.
Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide.
Lu WJ, Lee NP, Kaul SC, Lan F, Poon RT, Wadhwa R, Luk JM
Cell death and differentiation 2011 Jun;18(6):1046-56
Cell death and differentiation 2011 Jun;18(6):1046-56
Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide.
Widenmaier SB, Ao Z, Kim SJ, Warnock G, McIntosh CH
The Journal of biological chemistry 2009 Oct 30;284(44):30372-82
The Journal of biological chemistry 2009 Oct 30;284(44):30372-82
No comments: Submit comment
No validations: Submit validation data